ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,132,965 | +18.2% | 31,744 | +19.1% | 0.00% | 0.0% |
| Q2 2023 | $1,805,230 | +24.7% | 26,661 | +0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,447,199 | +3.2% | 26,652 | +13.8% | 0.00% | 0.0% |
| Q4 2022 | $1,402,800 | +44.3% | 23,429 | +9.1% | 0.00% | +50.0% |
| Q3 2022 | $972,000 | -20.6% | 21,480 | -2.1% | 0.00% | -33.3% |
| Q2 2022 | $1,224,000 | -81.4% | 21,945 | +3.2% | 0.00% | -76.9% |
| Q1 2022 | $6,576,000 | +410.6% | 21,261 | +7.9% | 0.01% | +550.0% |
| Q4 2021 | $1,288,000 | -11.3% | 19,712 | +1.8% | 0.00% | -33.3% |
| Q3 2021 | $1,452,000 | +2.4% | 19,360 | +6.6% | 0.00% | 0.0% |
| Q2 2021 | $1,418,000 | -3.3% | 18,165 | +1.5% | 0.00% | -25.0% |
| Q1 2021 | $1,467,000 | +3.6% | 17,890 | +4.2% | 0.00% | 0.0% |
| Q4 2020 | $1,416,000 | +29.8% | 17,161 | +1.9% | 0.00% | +33.3% |
| Q3 2020 | $1,091,000 | +12.6% | 16,841 | +7.6% | 0.00% | 0.0% |
| Q2 2020 | $969,000 | +10.2% | 15,656 | +14.0% | 0.00% | -25.0% |
| Q1 2020 | $879,000 | – | 13,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |